Lamivudine/pegylated interferon alfa‐2b sequential combination therapy compared with lamivudine monotherapy in HBeAg‐negative chronic hepatitis B - Concepedia

Concepedia

Publication | Closed Access

Lamivudine/pegylated interferon alfa‐2b sequential combination therapy compared with lamivudine monotherapy in HBeAg‐negative chronic hepatitis B

16

Citations

39

References

2007

Year

Themistoklis Vassiliadis, Kalliopi Patsiaoura, Thomas Zagris, Konstantinos Soufleris, Nikolaos Grammatikos, Konstantinos C. Theodoropoulos, Alexandros Mpoumponaris, Konstantina Dona, Petros Zezos, Nikolaos Nikolaidis,

Journal of Gastroenterology and Hepatology

Abstract

Sequential combination treatment is able to improve sustained biochemical response rates and prevent the emergence of lamivudine-resistant mutants in patients with HBeAg-negative chronic hepatitis B.

References

	Year	Citations
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B Patrick Marcellin, George Lau, Ferruccio Bonino, New England Journal of Medicine	2004	1.1K
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote, Gastroenterology HepatologyViral HepatitisPharmacologyHepatitis BHepatitis	2006	882
Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote, New England Journal of Medicine	2005	535
Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B W. G. E. Cooksley, Teerha Piratvisuth, Shin‐Da Lee, Journal of Viral Hepatitis	2003	476
Efficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Bb Nicolaos C. Tassopoulos, Riccardo Volpes, Giuseppe Pastore, Hepatology	1999	473
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. Carolina Boni, Antonio Bertoletti, Amalia Penna, Journal of Clinical Investigation ImmunologyHepatitis BPathologyChronic Hepatitis BImmunotherapy	1998	460
EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B13–14 September, 2002Geneva, Switzerland Journal of Hepatology HepatologyViral HepatitisImmunodeficienciesImmunologyHepatitis B	2003	438
Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B Stephanos J. Hadziyannis, George Papatheodoridis, Evangelini Dimou, Hepatology	2000	362
Long-term therapy of chronic hepatitis B with lamivudine Daryl Lau, Farooq Khokhar, Edward Doo, Hepatology ImmunologyHepatitis BPathologyChronic Hepatitis BPharmacotherapy	2000	350
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study Maurizia Rossana Brunetto, Filippo Oliveri, B. Coco, Journal of Hepatology Hepatitis DAutoimmune DiseaseHepatologyViral HepatitisImmunology	2002	333

Page 1